Tag Archives: Treatment

FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)

FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) Print this page DUBLIN–(BUSINESS WIRE)–Jan. 21, 2020– Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved Tepezza (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED). Tepezza is the first and only FDA-approved medicine for… Read More »

FDA Approves New Pancreatic Treatment Found To Double Time Patients Live Without Disease Progression

Pancreatic cancer is notoriously aggressive and difficult to treat but a recent FDA ruling may help put odds more in patients’ favor. Last week the FDA approved Lynparza for use as a maintenance treatment for certain pancreatic cancer patients. The drug was found to significantly expand the amount of time patients lived without disease progression. … Read More »

Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer

Print this page 30 December 2019 — AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that Lynparza® (olaparib) has been approved in the US for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) metastatic pancreatic adenocarcinoma whose… Read More »

Neurokinin Receptor Antagonists for the Treatment of Menopausal Symptoms

About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase.  For most, the symptoms are manageable, but for a sizeable subset of midlife women, these symptoms can negatively affect sleep, mood, and quality of life.  While clinical guidelines suggest that menopausal vasomotor symptoms… Read More »

“They’re just making me feel worse”: beliefs about HIV treatment among African and Caribbean people living in the UK

Qualitative research with African and Caribbean individuals living in the UK who have difficulties with adherence has revealed negative perceptions regarding antiretroviral treatment (ART). Interviewees had doubts about the need to take ART and concerns about taking ART, such as disclosure and side effects. Understanding these perceptions could guide future efforts to increase ART uptake… Read More »